Synthesis of novel C2-aryl pyrrolobenzodiazepines (PBDs) as potential antitumour agents.
Three novel C2-aryl substituted pyrrolobenzodiazepines (PBDs) have been synthesised and evaluated in a number of cell lines revealing selective cytotoxicity at the sub-nanomolar level towards melanoma and ovarian cancer cell lines.